ID: ALA1224419

Max Phase: Preclinical

Molecular Formula: C26H21Cl4N3O7

Molecular Weight: 629.28

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O)[C@H](Cc1ccc(OCc2c(Cl)cccc2Cl)cc1)NC(=O)[C@@H]1OCO[C@H]1C(=O)Nc1c(Cl)cncc1Cl

Standard InChI:  InChI=1S/C26H21Cl4N3O7/c27-16-2-1-3-17(28)15(16)11-38-14-6-4-13(5-7-14)8-20(26(36)37)32-24(34)22-23(40-12-39-22)25(35)33-21-18(29)9-31-10-19(21)30/h1-7,9-10,20,22-23H,8,11-12H2,(H,32,34)(H,36,37)(H,31,33,35)/t20-,22+,23+/m0/s1

Standard InChI Key:  OIQZAMZTLHTQQB-MDNUFGMLSA-N

Associated Targets(Human)

Integrin alpha-4 295 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 629.28Molecular Weight (Monoisotopic): 627.0134AlogP: 4.77#Rotatable Bonds: 10
Polar Surface Area: 136.08Molecular Species: ACIDHBA: 7HBD: 3
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 3.06CX Basic pKa: 2.29CX LogP: 4.36CX LogD: 1.25
Aromatic Rings: 3Heavy Atoms: 40QED Weighted: 0.29Np Likeness Score: -0.59

References

1. Rehman A, Soni A, Naik K, Nair S, Palle VP, Dastidar S, Ray A, Alam MS, Salman M, Cliffe IA, Sattigeri V..  (2010)  Synthesis and biological activity of N-substituted aminocarbonyl-1,3-dioxolanes as VLA-4 antagonists.,  20  (18): [PMID:20705461] [10.1016/j.bmcl.2010.07.069]

Source